• Novartis plans head-to-head studies of Cosentyx versus Humira

  • Jun 8 2016
  • Length: Less than 1 minute
  • Podcast
Novartis plans head-to-head studies of Cosentyx versus Humira By cover art

Novartis plans head-to-head studies of Cosentyx versus Humira

Listen for free

View show details

  • Summary

  • Long-term analyses suggest Cosentyx may lead to higher responses than Humira in improving signs and symptoms of ankylosing spondylitis and psoriatic arthritis...

    The post Novartis plans head-to-head studies of Cosentyx versus Humira appeared first on European Pharmaceutical Review.
    Show more Show less
Show more Show less

What listeners say about Novartis plans head-to-head studies of Cosentyx versus Humira

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available